CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+2.33%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$12B
AUM Growth
-$622M
(-4.9%)
Cap. Flow
-$654M
Cap. Flow
% of AUM
-5.44%
Top 10 Holdings %
Top 10 Hldgs %
21.36%
Holding
837
New
29
Increased
81
Reduced
102
Closed
16
Top Buys
| 1 |
AstraZeneca
AZN
|
+$5.57K |
| 2 |
Royal Bank of Canada
RY
|
+$3.71K |
| 3 |
Amgen
AMGN
|
+$3.31K |
| 4 |
Rio Tinto
RIO
|
+$3.18K |
| 5 |
Arrow Electronics
ARW
|
+$3K |
Top Sells
| 1 |
New Oriental
EDU
|
+$361M |
| 2 |
Varonis Systems
VRNS
|
+$46.6M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$27.7M |
| 4 |
OSB
Norbord Inc.
OSB
|
+$16.7M |
| 5 |
QEP
QEP RESOURCES, INC.
QEP
|
+$13.7M |
Sector Composition
| 1 | Healthcare | 34.24% |
| 2 | Technology | 22.74% |
| 3 | Consumer Discretionary | 9.48% |
| 4 | Financials | 7.93% |
| 5 | Communication Services | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Illinois Tool Works
ITW
$76.4B
| $5.44M | 0.05% |
27,785
| – | – |
|
352
Target
TGT
$41.3B
| $5.39M | 0.04% |
31,774
| – | – |
|
353
American International
AIG
$43.5B
| $5.39M | 0.04% |
148,094
| – | – |
|
354
Interpublic Group of Companies
IPG
$9.74B
| $5.37M | 0.04% |
237,600
-29
| -0% | -$655 |
|
355
Okta
OKTA
$16.5B
| $5.37M | 0.04% |
21,976
| – | – |
|
356
Pfizer
PFE
$140B
| $5.29M | 0.04% |
149,694
| – | – |
|
357
Eversource Energy
ES
$23.7B
| $5.26M | 0.04% |
63,339
| – | – |
|
358
Infosys
INFY
$70.5B
| $5.23M | 0.04% |
321,238
| – | – |
|
359
Akamai
AKAM
$11.2B
| $5.23M | 0.04% |
51,853
| – | – |
|
360
DexCom
DXCM
$30.7B
| $5.23M | 0.04% |
58,900
| – | – |
|
361
Teladoc Health
TDOC
$1.38B
| $5.19M | 0.04% |
27,034
| – | – |
|
362
Huntington Ingalls Industries
HII
$10.5B
| $5.17M | 0.04% |
31,589
| – | – |
|
363
Cogent Biosciences
COGT
$1.79B
| $5.12M | 0.04% |
474,809
+79
| +0% | +$852 |
|
364
Live Nation Entertainment
LYV
$39.5B
| $5.11M | 0.04% |
72,353
| – | – |
|
365
Otis Worldwide
OTIS
$34.5B
| $5.11M | 0.04% |
78,675
| – | – |
|
366
CSX Corp
CSX
$60B
| $5.06M | 0.04% |
174,039
+6
| +0% | +$174 |
|
367
Fifth Third Bancorp
FITB
$30.1B
| $5.04M | 0.04% |
190,296
| – | – |
|
368
NetApp
NTAP
$24.6B
| $5.02M | 0.04% |
78,918
| – | – |
|
369
Nektar Therapeutics
NKTR
$924M
| $5M | 0.04% |
20,406
| – | – |
|
370
Exelon
EXC
$43.5B
| $4.97M | 0.04% |
171,836
| – | – |
|
371
Charles Schwab
SCHW
$170B
| $4.92M | 0.04% |
96,577
| – | – |
|
|
XYZ
372
Block, Inc.
XYZ
$46B
| $4.89M | 0.04% |
23,368
| – | – |
|
373
Tandem Diabetes Care
TNDM
$849M
| $4.81M | 0.04% |
52,370
| – | – |
|
374
DuPont de Nemours
DD
$32.1B
| $4.75M | 0.04% |
69,604
| – | – |
|
375
Masimo
MASI
$8.05B
| $4.69M | 0.04% |
18,179
| – | – |
|